MedTrace Logo

Validate Non-invasive Prenatal Tests for the Detection of Chromosomal Abnormalities

NCT05618431 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1790

Last updated 2023-12-06

No results posted yet for this study

Summary

This study will be conducted on pregnant patients for whom there is a suspicion of a chromosomal abnormality of the fetus. These are patients eligible for non-invasive prenatal screening as part of their usual pregnancy surveillance. This research aims to develop and validate a new method for non-invasive prenatal testing.

This prospective collection study will allow the collection of biological samples necessary for the development, testing and validation of these new tests

Conditions

  • Validation of New Test NIPT

Interventions

OTHER

NIPT

This research aims to develop and validate a new method for non-invasive prenatal testing

Sponsors & Collaborators

  • CerbaXpert

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2024-06-01
Completion
2024-06-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05618431 on ClinicalTrials.gov